Close Menu

NEW YORK – Beckman Coulter announced Tuesday that the US Food and Drug Administration granted 510(k) clearance to its Access PCT assay, allowing it to be sold in the US.

The in vitro diagnostic test allows physicians to assess critically ill patients who may be in danger of progressing to severe sepsis or septic shock by measuring procalcitonin levels in blood.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.